Surgical treatment of recurrent differentiated thyroid carcinoma

European Journal of Surgery, Supplement

Volumn 168, Issue 588, 2003, Pages 14-17

  Dávila Cervantes, Andrea ^a   Gamino, Rosa ^a   González, Ofelia ^a   Herrera, Miguel F ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Cancer; Follicular carcinoma; Papillary carcinoma; Recurrence; Thyroid; Thyroid carcinoma

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CELL DIFFERENTIATION; CERVICAL LYMPH NODE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MEXICO; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RADIATION DOSE; RADIOIODINATION; RECURRENT CANCER; RETROSPECTIVE STUDY; THYROID CARCINOMA; THYROID GLAND; THYROID SURGERY; THYROIDECTOMY; TREATMENT OUTCOME; ADENOCARCINOMA; CARCINOMA; LYMPHADENECTOMY; MIDDLE AGED; PAPILLARY CARCINOMA; THYROID TUMOR; TUMOR RECURRENCE;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS;

EID: 0043166760     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cady B. Our AMES is true: how an old concept still hits the mark or risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 1997; 174: 462-468.
2. Cady B, Sedgwick CE, Meissner WA, et al. Risk factors analysis in differentiated thyroid carcinoma. Cancer 1979; 43: 810-820.
3. Clark OH. Total thyroidectomy the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982; 196: 361-366.
4. Düren E, Düren M. Recurrent thyroid cancer. In: Clark OH, Duh QY eds. Textbook of endocrine surgery, Philadelphia: WB Saunders, 1997; 141-146.
5. Farrar WB, Cooperman M, Jones AG. Surgical management of papillary and follicular carcinoma of the thyroid. Ann Surg 1980; 192: 701-704.
6. Frankenthaler RA, Sellin RV, Cangir A, Goepfert H. Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg 1990; 16; 341-343.
7. Hamby LS, McGrath P, Schwartz R, et al. Management of local recurrence in well-differentiated thyroid carcinoma. J Surg Res 1992; 52: 113-117.
8. Hay ID, Grant CS, Taylor W, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102: 1088-1096.
9. Herrera MF, López-Graniel C, Saldaña J, et al. Papillary thyroid carcinoma in Mexican patients: clinical aspects and prognostic factors. World J Surg 1996; 20: 94-100.
10. 131I therapy in the management of thyroid cancer: A prospective study. Cancer 1997; 40: 195-202.
11. LoGerfo P, Chabot J, Gazetas P. The intraoperative incidence of detectable bilateral and multicentric disease in papillary cancer of the thyroid. Surgery 1990; 108: 958-962.
12. Maxon HR, Thomas SR, Hertzgerg VS, et al. Relation between effective radiation dose and outcome of radio-iodine therapy for thyroid cancer. N Engl J Med 1983; 18: 600-604.
13. 131I in the treatment of thyroid cancer. Thyroid Today 1993; 16: 1-9.
14. McConahey WM, Hay ID, Woolner LB, Van Heerden JA, Taylor WF. Papillary thyroid cancer treatment at Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 1986; 61; 978-996.
15. Nguyen K, Dilawari R. Predictive values of AMES scoring system in selection of extent of surgery in well differentiated carcinoma of thyroid. Am Surg 1995; 50: 151-155.
16. Noguchi S, Noguchi A, Murakami N. Papillary carcinoma of the thyroid II Value of prophylactic lymph node excision. Cancer 1970; 26: 1061-1064.
17. Ozaki O, Sugino K, Yasuda K, et al. Surgical strategy for patients with recurrent carcinoma of the thyroid. Endoc Surg 1990; 7: 405-410.
18. Samaan N, Maheshwari Y, Nader S, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983; 56: 1131-1136.
19. Schoreder DM, Chambers A, France CJ. Operative strategy for thyroid cancer: Is total thyroidectomy worth the price? Cancer 1986; 58: 2320-2328.
20. Tollefson H, Shah JP, Huvos AG. Papillary carcinoma of the thyroid recurrence after initial surgical treatment. Am J Surg 1972; 124: 468-472.
21. 131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 2675-2680.
22. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985; 55: 794-804.
23. Tubiana M. External radiotherapy and radioiodine in the treatment of thyroid cancer. World J Surg 1981; 5: 75-82.
24. Vassilopoulou-Sellin R, Schultz P, Haynie T. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 1996; 78: 493-499.
25. Wartofsky L. Thyroid cancer. In: A comprehensive guide to clinical management. New Jersey: Humana Press, 2000.